- The Greenfields: Get ahead in the cannabis business
- Posts
- 🌿 Viroid threatens cannabis industry 🦠
🌿 Viroid threatens cannabis industry 🦠
PLUS: Is TYSON 2.0 coming to AUS?👂, Emyria's high CBD capsule, ECS Botanics grow revenue
Good morning Greenies. We’ve got a lot to catch up on after having a break Tuesday, so let’s get stuck into it.
What’ve we got for you today?
Viroid threatens cannabis industry 🦠
Is TYSON 2.0 coming to Aus? 👂
Photos of People (or Cats) Surrounded by Cannabis 📸
ECS Botanics quarterly receipts up 256% 📊
Emyria’s high (😉) CBD capsule 💊
Viroid threatens cannabis industry 🦠
A viroid that can drop THC and CBD levels by 40% and lower yields is threatening the worldwide cannabis industry.
Known as Hop Latent Viroid (HLVd), experts think it has spread around the world thanks to the cannabis industry’s heavy reliance on clones.
“So everybody is shipping clones from here to there, and nobody was testing, or nobody was aware of any methodology to test for this virus.
“What we did was basically spread it all over the planet. Anybody receiving any plants from the United States, especially from California, has the viroid in their grow.”
30% of cannabis plants in the US are estimated to be infected with HLVd. This translates into an estimated annual loss of $4 Billion based on the 7 million pounds of cannabis produced in the US during 2021.
Help is available though. Dark Heart Nursery says they can detect and remove the viroid from plants. Front Range Biosciences also have a method for removing the viroid using tissue culture.
Photos of People (or cats) Surrounded by Cannabis 📸
This weeks Photos of People (or Cats) Surrounded by Cannabis is from Jacob Roloff of organic cannabis growers Helvetia Gardens.
This is Jacob with last autumns plants.
Good for you Jacob.
If you'd like to see your photo in Photos of People (or cats) Surrounded by Cannabis share it with us on Twitter, Facebook, LinkedIn or Instagram.
Is TYSON 2.0 coming to AUS? 👂
InterCure Ltd has licensed the Mike Tyson branded TYSON 2.0 in Australia, Israel, United Kingdom, Germany and other EU countries. The agreement gives InterCure the exclusive distribution license to cultivate, manufacture, sell, market, and distribute TYSON 2.0 products.
InterCure are based in Israel and operate CannDoc a producer of pharmaceutical grade medicinal cannabis. They haven’t given any indication when TYSON 2.0 products will come to Australia and what products will be offered.
Ear biter Mike Tyson launched the TYSON 2.0 brand about a year ago and generated about $50 million in revenue so far. Their product range includes three different types of flower and edibles in the shape Evander Holyfields ear.
As far as we are aware this would be the first celebrity-branded cannabis product to come to Australia. It’ll be interesting to see how this works in Australia because rules banning advertising medicines will make celebrity branding much less effective.
Like The Greenfields?
Send this email to a friend to make sure they don't fall behind in the cannabis business.
Are you the friend? Click the button to subscribe for free:
Emyria’s high (😉) CBD capsule
Emyria (ASX:EMD) has announced a high CBD capsule called EMD-RX9 for people requiring higher doses of CBD.
The capsule aims to deliver doses of CBD higher than 150mg in a single pill which is more convenient for patients on high doses because they have to take less pills.
Emyria are planning to conduct a Phase 1 head-to-head study against Epidyolex. Epidyolex is the only registered CBD medication on the market worldwide.
ECS Botanics quarterly receipts up 265%
ECS Botanics (ASX:ECS) announced quarterly receipts of $4.37 million and revenues of $3.78 million for the March quarter. Quarterly cash receipts were up 265% over the same quarter last year.
They attribute the growth to strong demand for their products. Sales in March reached a record $2.41 million, up 36% over the previous month.
ECS also signed an agreement with Ilios Sante to send a minimum of $9.9 million worth of cannabis products to Germany over three years.
Things are going so well at ECS they are looking at ways to extend their growing season, but didn’t provide any further details on how they’d do this.
More Cannabis News
Medicinal Cannabis Australia launched it’s range of dried-flower and inhalation cartridges
MedCan showed off their new grow facility to A Current Affair
Cannaponics held an investor webinar for their crowdfunding campaign
Cannabis clinics Herbal Health Clinics and MCGP merge
Medicinal cannabis treats AFL, NRL players with traumatic brain injuries
What did you think of todays newsletter?
That’s your walk through The Greenfields of the cannabis industry today. We hope you've enjoyed it.
DISCLAIMER: This newsletter is not financial advice. It is strictly educational and is not investment advice or a solicitation to buy or sell anything or to make any financial decisions. Please do your own research and do not buy anything dodgy.
Reply